Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
iNtRON to Seek a New Clinical Partner for SAL200 Endolysin 2022-06-28 21:00
New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos 2022-06-28 19:07
Seegene develops PCR test to detect monkeypox virus 2022-06-28 19:00
Ascletis Announced First Subject Dosed in the Phase II Clinical Trial of ASC22 (Envafolimab) for Immune Restoration/ Functional Cure of HIV-1 Infection 2022-06-28 18:11
DeepGI - A Thai Innovation for the Precision in Colorectal Polyp Detection 2022-06-28 13:02
Sanofi Enters into a Partnering Agreement with Health2Sync 2022-06-28 11:00
IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program 2022-06-28 09:05
Cargene Biopharma Welcomes Kathy He as CEO, to Accelerate Novel Oligonucleotide Therapeutics Development 2022-06-28 09:00
Transcenta was Selected to Present the Preclinical Data of TST004 at the 2022 ISN Frontiers Meetings of Complement Related Kidney Diseases 2022-06-28 08:00
Harbour BioMed Announces IND Clearance for B7H4x4-1BB Bispecific Antibody by the U.S. Food and Drug Administration 2022-06-27 19:04
Amcor Lift-Off initiative shortlists start-ups for seed funding 2022-06-27 17:03
BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project 2022-06-27 16:20
JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omicron subvariants BA.4 and BA.5 2022-06-27 15:30
Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines 2022-06-27 14:47
Abcam: Appointment of Vice President of Investor Relations 2022-06-27 14:00
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma 2022-06-27 08:30
Ascletis' Subcutaneous PD-L1 Antibody ASC22 Demonstrated Potential of Functional Cure of Chronic Hepatitis B as 42.9% of Patients with Baseline HBsAg≤100 IU/mL Obtained Sustained HBsAg Loss 2022-06-27 08:11
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma 2022-06-27 08:00
Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application 2022-06-26 08:00
Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D 2022-06-25 08:00
1 235 236 237 238 239 894